Clover Health Investments, Corp. (NASDAQ: CLOV) is a Healthcare company (Medical - Healthcare Plans) with a market capitalization of $2.5B. The Maz Rating grades it against the other companies in its sector.
Clover Health Investments, Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $4.73, Clover Health Investments, Corp. trades at 276.5x trailing earnings, 0.9x sales and 6.4x book value, with an EV/EBITDA of 152.9. Over the last twelve months it generated about $2.8B of revenue and $9M of net income. It runs a gross margin of 18.9%, an operating margin of 0.5% and a net margin of 0.5%. It shows return on equity of 3.5%, return on invested capital of 3.1% and a free cash flow yield of 5.3%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 1.55. Over the past 52 weeks the share price ranged from $1.58 to $5.59, with a beta of 2.48.
Clover Health Investments, Corp. does not currently pay a dividend.
9 Wall Street analyst ratings cover the stock: 1 Buy, 5 Hold and 3 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.